Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
Apply
Cabozantinib & Durvalumab
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step